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Abstract
The aim of this study was to describe the epidemiology of necrotising enterocolitis (NEC), antibiotic consumption and the
usefulness of microbiological tests in very low birth weight (VLBW) Polish newborns.
Methods: Prospective surveillance was performed in the year 2009 by local infection control teams. The study covered 910
infants hospitalized in six Polish neonatal intensive care units. Two kinds of indicators were used for the description of
antibiotic usage: the duration of treatment (days of treatment, DOTs) and the defined daily dose (DDD).
Results: NEC incidence was 8.7% and fatality rate was 19%. Chorioamnionitis, late gestational age and low birth weight
were identified as risk factors for NEC. Catheterization, mechanical ventilation and other selected procedures were used
considerably longer in newborns with NEC than in the remaining neonates. Total usage of antibiotics reached 2.9 DDDs or
1.437 days; the average use of drugs per case of NEC amounted to 0.47 DDD or 23.2 DOTs. The level of antibiotic usage was
analysed with correlation to microbiological tests performed and it was non-significantly greater in the group of children
with NEC in whom the tests were performed.
Conclusions: A high risk of developing NEC is closely associated with VLBW and with inflammation of the amnion during
labour. We observed no relationship between the consumption of antibiotics in neonates with NEC and positive results of
microbiological testing indicating sepsis accompanying NEC or gut colonization with pathogens.
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Introduction
Necrotising enterocolitis (NEC) is one of the most unpredictable
and devastating diseases in premature infants. To date there is no
one theory as to the etiology of NEC; however, most researchers
agree that the pathogenesis is multifactorial and has often been
associated with enteral feedings, bowel ischemia and infectious
causes [1]. The process leading to NEC is thought to be preceded
by an ischemic or toxic event that causes damage to the immature
gastrointestinal mucosa and loss of mucosal integrity [2]. The
initiation of enteral feedings allows for bacterial proliferation at
which time the damaged mucosa is invaded by gas-producing
bacteria. This process may lead to necrosis which can cause either
perforation of the bowel or sepsis [3] and then may often lead to
sepsis caused by translocation of gut colonizing nosocomial
pathogens in the peritoneum and/or blood [4].
With an incidence of 6–7%, NEC is also one of the leading
causes of mortality among infants [5–8]. It is a big and costly
problem especially for infants who are born with very low birth
weight (VLBW). In a study by Ganapathy and co-workers, the
adjusted incremental costs of NEC were more than $198,000 (U.S.
dollars) per infant in their 2012 report [9].
The aim of the study was to investigate the incidence rate of
NEC among VLBW neonates, determine selected risk factors
accompanying sepsis and gut colonization by nosocomial patho-
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gens, and assess the level of antibiotic usage and its correlation to
performing microbiological tests.
Methods
Electronic database created as the result of continuous
prospective targeted surveillance of infections was used in the
study. Data were collected between 1.01.2009 and 31.12.2009 in
six tertiary academic neonatal intensive care units (NICU) that
took part in the Polish Neonatology Surveillance Network (PNSN).
The PNSN is a prospective national surveillance system for the
most relevant infections in VLBW infants (birthweight , 1500 g)
in Poland. Details of the following variables were collected for all
VLBW newborns: birthweight and gestational age, gender,
multiple pregnacy, type of delivery and information of the
situation in time of delivery, for example chorioamnionitis, general
status of newborns by Apgar score: at 1 and 5 minutes and Critical
Risk Index for Babies, CRIB and others). The PNSN recorded
severe infections, including necrotizing enterocolitis observed in
the time on hospitalization: from admission to discharge, transfer
or death. Participation in PNSN was voluntary and confidential.
Utilization of data collected in PNSN for the scientific purpose was
approved by the Bioethics Committee of Jagiellonian University
Medical College – no. KBET/221/B/2011. All data entered into
the electronic database and analyzed during preparing this article
were previously anonymized and de-identified. Those data were
obtained under routine treatment and diagnostic procedures
performed during patients’ hospitalization. According to Polish
law, utilization this kind of data for scientific purpose does not
demand patients’ agreement or even information that data are
collected in the database. Before analysis incomplete records were
deleted and as the result all records of 485 newborns without NEC
and 79 NEC cases were filled with all data.
Thus, the utilization of those data for the analysis is consistent
with the Polish law and approved by the institutional University
bioethics committee.
Infants with birth weight lower than 1,500 grams were included
in the study. Case NEC patients were defined according to
Gastmeier et al [10] as neonates with VLBW who had clinical
symptoms of necrotising enterocolitis (NEC), i.e., at least two of
the following signs: vomiting, abdominal distention, pre-feeding
residuals, redness of flanks, persistent microscopic or gross blood in
stools; and at least one of the following criteria: pneumoperitone-
um, pneumatosis intestinalis, unchanging ‘rigid’ loops of small
bowel; or histological evidence of NEC, considered as infection.
Standard indicators of general status of newborns was Apgar
score (at 1 and 5 minutes) and Critical Risk Index for Babies
(CRIB). Chorioamnionitis diagnosis was based on clinical evalu-
ation without the need for microbiological or histopathological
examination [11].
The amount of human milk provided in natural feeding was not
described in study protocol in a quantitative manner.
Microbiological tests were performed in some neonates
according to doctor’s orders and the presence of clinical symptoms
of NEC. Blood or rectal swabs were collected (any signs of NEC)
for culture and assessment of the presence of facultative pathogens.
The specimens were cultured on McConkey agar, horse blood
agar and Sabouraud agar (37uC, 24 h each). Identification with
API tests (bioMerieux) was then performed.
Antibiotic usage for NEC treatment (until cure) was assessed for
59 cases; eight cases were excluded from analysis due to death of
the infants in the first seven days of NEC (unsuccessful treatment).
The elimination of one case was connected with an internal
validation of data (extremely high consumption of antibiotics, i.e.,
more than 10 times greater than in other cases, suggesting
recording bias). In other cases (nine newborns), data about
treatment were not available. Two kinds of indicators were used
for the description of antibiotic usage: the duration of treatment
(days of treatment, DOTs) expressed in days and the defined daily
dose (DDD), according to the ATC/DDD system of the World
Health Organization (Anatomical Therapeutic Chemical, group
‘‘J01’’), both measures in reference to one case of infection.
For the evaluation of the differences between the averages for
the examined groups of infants (the examined group with NEC vs
the infants without any infections), one-way analysis of variances
(ANOVA) with the least significant difference (LSD) test and the
Tukey’s test were applied. For the assessment of the frequency of
infections in various groups of infants, the chi-square test of
independence was used. A nonparametric Mann-Whitney U test
was applied to assess the significance of differences between the
length of antimicrobial treatment of infections or the number of
DDD and positive result of microbiological tests. The calculations
were performed with the application of the SciPy open source
library; the assumed significance level was p,0.05.
Results
Characteristics of study population
The activities of the PNSN covered 910 VLBW newborns
including 166 extremely low birth weight infants (18.2%) with a
birth weight up to 750 grams, 250 infants (27.5%) with birth
weight ranging from 751 to 999 grams and 494 infants (54.3%)
with birth weight ranging from 1,000 to 1,500 grams. The number
of VLBW newborns covered by the survey accounted for 19.1% of
all VLBW infants born in Poland in 2009.
Their mortality rate within the entire country of Poland was
24.3%, while in the examined units it averaged 19%12 Overall,
812 deliveries were described, 223 infants were born from multiple
pregnancies. All wards had perinatal care and were in the tertiary
referral teaching hospitals.
The most frequently observed symptoms of NEC were:
abdominal distension (98.5% of cases), pre-feeding residuals/
gastric retention (97.5%), impaired intestinal motility (79.4%),
elevated C-reactive protein (73.5%) and radiographic signs
(33.8%).
Among the hospitalised infants, 425 had at least one infection;
79 infants had symptoms of NEC. The NEC incidence was 8.7%,
the risk of NEC development did not differ between centres. Thus,
newborns with NEC accounted for 12.7% of all, that was 625
cases of infection.
Risk Factor Analysis
Among the children with NEC, 63 (79.7%) were breastfed. One
NEC case was observed among infants who were not provided
with total parenteral nutrition (TPN), incidence rate – 1.7%. The
NEC symptoms in this case were observed at the 27th day of life of
the neonate born with a birth weight of 1,480 grams.
The mean gestational age and birth weight of the premature
with NEC were significantly lower (median: 27) than the mean
gestational age in the group of newborns without any infections
(median: 28) (Table 1); the significantly higher incidence rate
(11.8%) was confirmed in the group of infants with birth weight
less than 1,000 grams (relative risk, RR 1.9).
Statistical analysis of the relationship between the occurrence of
NEC and chorioamnionitis diagnosed in mothers showed that this
relationship was statistically significant (p,0.005), but the RR and
95% CI values did not allow an unambiguous assessment of this
relationship (RR 2.1, 95% confidence interval, CI 0.9143-4.4092).
NEC in VLBW Newborns in Poland
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The gender of the infants did not influence the risk of NEC;
neither did the general condition of the infant as expressed by the
CRIB score and the APGAR score at 1 and 5 minutes after birth.
The occurrence of a single vs multiple pregnancy (twin birth,
triplet birth or more) decreased the risk of NEC (RR 0.01, 95% CI
1.4187-5.8781). The type of feeding, natural, trophic, or
parenteral, did not influence the risk of NEC in studied group of
VLBW infants (Table 1).
Correlation between selected risk factors and observed
outcomes
Newborns with NEC symptoms were more frequently vulner-
able to late-onset pneumonia (according to Gastmeier et al [12])
(RR 2.2, 95% CI 1.930205.1491). Catheterisation, mechanical
ventilation, antibiotic use and other selected procedures (as a
consequence of NEC) were used for a significantly longer period of
time in newborns with NEC (p,0.001) (Tab. 1) compared to
neonates without any infections.
NEC was the direct cause of death in 18 newborns, fatality case
rate was 22.8%.
Microbiological assays in neonates with NEC and
antibiotic consumption
Microbiological tests performed using the culture method for
the determination of facultative pathogens were done in 85.2% of
the cases. Presence of bacterial strains regarded as facultative
pathogens in blood or rectal swabs was confirmed in 53% of
samples. Gram-positive cocci were most frequently isolated and
constituted 62.9% of all microorganisms; coagulase-negative
staphylococci were the most often detected among them
(42.9%). Gram-negative rods were isolated with a frequency of
34.3% (total); Escherichia coli – 11.4%, Klebsiella spp – 17.1% and
Enterobacter spp. of 5.7% of all cases (Table 2). Yeasts constituted
2.9% of all cases.
In the analysed group, 29.4 DDDs of antibiotics were used for
treatment of NEC and total treatment duration was 1,437 days
(Table 3). Average usage of antimicrobials in all wards was 23.2
DOTs or 0.5 DDDs per case. The lowest antibiotic usage was
observed in ward B – 9.27 DOTs or 0.2 DDDs; the highest in
ward C – 46.0 DOTs or 0.9 DDDs (about four times higher). The
differences observed were related to the monitoring of the
infections carried out in NICUs, which was reflected in the fact
that the overall incidence rate was twofold higher in ward C. The
antibiotics most often used for treatment were beta-lactams,
aminoglycosides, glycopeptides and metronidazole; the percentage
Table 1. Characteristics of neonates with symptoms of NEC and newborns without signs of any infections.
Number of newborns
Without NEC or others infetciotns [N = 485] With NEC [N = 79]
mean 95%CI mean 95%CI p- value
Gestational age [week] 28 28; 29 27 26; 27 ,0.001
Birth weight [gram] 1 058 1 029; 1 087 918 861; 974 ,0.001
Participated in the study group N % N %
Female 233 48.0 32 40.5 –
Caesarean sections 339 69.9 55 69.6 –
Single pregnancy 340 70.1 70 88.6 ,0.001
Trophic feeding 181 37.3 35 44.3 –
CRIB* N % N %
0–4 101 20.8 12 15.2 –
5–10 26 5.4 7 8.9 –
11–15 10 2.1 2 2.5 –
15–22 8 1.6 0 0.0 –
Apgar (1 min) N % N %
0–4 183 37.7 29 36.7 –
5–7 199 41.0 35 44.3 –
8–10 103 21.1 15 19.0 –
Apgar (5 min) N % N %
0–4 129 26.6 22 27.8 –
5–7 201 41.4 39 49.4 –
8–10 155 32.0 18 22.8 –
PROM 106 21.9 22 27.8 –
Chorioamnionitis diagnosed during pregnancy 26 5.4 9 11.4 –
Fatal cases 120 24.7 16 20.3 –
CI – confidence interval; CRIB – Clinical Risk Index for Babies; NEC – necrotizing enterocolitis; PROM – prolonged rupture of membranes;
*CRIB index was calculated and used unly in two of six NICUs taking part in this analysis.
doi:10.1371/journal.pone.0092865.t001
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of treatment duration for these groups of antimicrobials was
35.8%, 5%, 14.3% and 12.5%, respectively. The only antifungal
drug used in the treatment was fluconazole, for 19% of the
treatment days.
According to both indicators, i.e. duration of treatment and
DDDs, antibiotic usage was non-significantly greater in the group
of 38 infants with NEC in whom microbiological tests were not
performed. In this group, the average usage of antibiotic treatment
was 28.0 DOTs or 0.6 DDD per case. Antibiotic consumption was
lower in the group of 21 NEC infants in whom microbiological
tests were performed, and amounted to 18.6 DOTs or 0.4 DDD
per one case of infection. Data concerning antimicrobial
consumption in reference to microbiological tests in individual
NICUs are presented in Table 4.
Discussion
Our results of late-onset infections are the first to be reported by
the PNSN and from Central (except NeoKISS) Europe based on a
national programme for infection control in neonatal units. In
Poland, fewer than 5000 VLBW infants are born each year, i.e.,
0.9% of all live births [13].
In the literature, incidence attributed to NEC is assessed at a
level of 6–7%, and the authors indicate a large variability of the
reported values depending on the population studied [12,14,15].
According to Gagliardi, the highest incidence reaching 13%, was
observed among newborns delivered in the 24th week of
pregnancy, while the incidence rate of NEC among infants
delivered in the 27th week or later was as low as 3% [16]. Thus,
the mean gestational age of premature newborns in our population
was 28 weeks (median: 27) suggesting that the incidence rate in the
Polish population studies is higher than those observed in other
studies.
Among the most important risk factors for developing NEC, the
following are considered important: low Apgar score [17], the
need for surfactant application, patent ductus arteriosus and late-
onset bloodstream infections [16]. In the recent review on NEC
[18], the following risk factors were also listed: prematurity (,28
weeks), enteral feeding (90% are fed enterally), growth restriction,
maternal hypertensive disease of pregnancy, placental abruption,
absent or reversed end diastolic flow velocity, use of umbilical
catheters and packed cell transfusions. Such a great range of
factors may indicate a lack of certainty referred to etiology of this
clinical entity, although a proposed concept of NEC pathologic
mechanisms [18] seems to indicate a progress in understanding its
pathomechanisms.
The presented results indicate a close correlation between NEC
incidence and chorioamnionitis. Thus, our findings are in
concordance with a recent review by Been et al [19]. Their
meta-analysis indicates an important role of antenatal inflamma-
tion in NEC development. This factor has not yet been analysed in
detail, but may suggest a potential relationship between NEC and
improper gut colonisation during the neonatal period, or at the
moment of birth, which has already been indicated by other
authors [20–22].
Other procedures, which have not been analysed in the present
study but may influence NEC incidence, such as the use of
probiotics [23,24], L-arginine [25], lactoferrin [26] or the
extended empirical antibiotic treatment [17] still require intensive
multicentre studies.
Also, current trial data do not provide evidence that delayed
introduction of progressive enteral feeds reduces the risk of NEC
in VLBW infants [27].
Sepsis is an infection accompanying NEC. In the study
published by Salbah et al [4], the proportion of infants with
culture-proven nosocomial sepsis was higher in the NEC group
than in controls without NEC. Of the organisms isolated from the
NEC infants 50% were Gram-negative bacilli as compared to 14%
in the controls; 44% of the organisms isolated from the NEC cases
were Gram-positive cocci as compared to 72% in the controls.
Fungal infections occurred in 6% of the NEC cases as compared to
14% in the controls [22]. We obtained very similar data from our
observations, although in general Gram-positive cocci predomi-
nated over Gram-negative rods in cultures obtained from blood of
the NEC group. Cultures from rectal swabs, which represent gut
colonization, showed a predominance of Gram-negative rods over
Table 2. Microorganisms isolated from blood or rectal swabs
of neonates with NEC.
Type of material
tested
Species Blood Rectal swabs Total %
Staphylococcus aureus 2 0 3 5.7
Coagulase negative staphylococci 9 6 15 42.9
Enterococcus spp. 1 4 5 14.3
Escherichia coli 3 1 4 11.4
Klebsiella spp. 0 6 6 17.1
Enterobacter spp. 0 2 2 5.7
Candida spp. 0 1 1 2.9
TOTAL 15 20 35 100.0
doi:10.1371/journal.pone.0092865.t002
Table 3. Antibiotic usage in NEC cases according to studied NICUs.
Ward DOTs [day] DOTs per number of NEC DDDs [no] DDDs per number of NEC
A 98 12.25 0.3 0.3
B 102 9.27 0.2 0.2
C 322 46.00 0.6 0.9
D 218 27.25 0.4 0.5
E 376 31.33 1.0 0.8
F 321 20.06 4.3 0.3
TOTAL 1 437 23.18 29.4 0.5
NEC – necrotizing enterocolitis; DDD – defined daily dose; DOTs – days of treatment;
doi:10.1371/journal.pone.0092865.t003
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Gram-positive cocci. Coagulase negative staphylococci (CoNS)
were the only Gram-positive microorganism isolated from rectal
swabs and its role as a potential etiological factor of NEC was
examined previously by others. Hoy et al noted the presence of
CoNS in duodenal aspirates of VLBW infants, they are commonly
found in the stools of NEC infants and have been associated with
serious diseases [28]. The role of staphylococcal delta(d)-toxin was
examined by Scheifele et al and Scheifele and Bjornson, who
believed that toxin positive CoNS were enteropathic. d-toxin, a
secreted protein with a detergent-like action, caused significant
bowel necrosis in infant rats and was cytotoxic for fibroblasts in
vitro [29,30]. Moreover, it could be detected in the stools of infants
colonised with d-toxin producing CoNS. Rejection of the d-toxin
theory does not preclude a role for CoNS per se, which are known
to express a number of other virulence factors. In addition,
preterm infants exhibit deficiencies in immune responses to CoNS,
suggesting they may cause more aggressive infections in this group
compared to term neonates [31].
The problem of the diagnostic value of microbiological test
results obtained during NEC is not often discussed at present by
researchers. The reason for this may be diagnostic difficulties
concerning the choice of clinical materials (samples) and micro-
biological tests that enable obtaining the results indicative for
antibiotic treatment. At the moment, no recommendations in this
area exist, since a possible microbial aetiology of NEC remains
obscure. A good diagnostic material could definitely be, e.g.,
peritoneal fluid [32], but it is available only in patients in whom
surgical intervention is required.
It is of interest that although various antibiotic regimens are
commonly and widely used in the treatment of NEC, there is no
sufficient evidence to recommend a particular antibiotic for its
treatment [33]. Even though microbial aetiology remains
unknown, preventing and treating sepsis with antibiotics yet
avoiding prolonged exposure to them is equally important [34].
The results of this study confirm that bias: the utilisation of the
microbiological diagnostic tests in neonates with NEC did not
influence the level of antibiotic usage expressed by either DOTs or
DDDs, the influence of results of the microbiological diagnostics
on the scheme of treatment is unknown.
Creating and managing antibiotic policy is one of the main
elements of the infection surveillance. The most commonly used
measure of drug consumption is the defined daily dose, which is
the assumed average maintenance dose per day of drug use for its
main indication in adults. In premature, the direct measurement
of the number of days of treatment (DOTs) may have a better
application. Both measures were used in this study. Antibiotic
usage in the treatment of NEC cases in hospitals taking part in the
study varied both using the DOT or DDD rate per case, especially
comparing the level of antibiotic usage in ward B and in ward C –
where it was about four times higher. The differences observed
were related to the monitoring of the infections carried out in
NICUs, which was reflected in the fact that the overall incidence
rate was twofold higher in ward C. This confirms that a lack of
infection observation is also a lack of antibiotic consumption
observation.
Average values of antibiotic usage in the group of NEC cases
with microbiological support were non-significantly lower and
reached 18.6 DOTs or 0.4 DDDs per case, contrary to the group
of NEC cases without microbiological testing, where the usage was
28.0 or 0.6, respectively (about 70% higher). Due to the relatively
small sample size, further research indicating the possibility of the
application of microbiological diagnostics in neonates with NEC is
necessary because of frequent sepsis cases caused by common
hospital pathogens such as staphylococci and Gram-negative rods.
Perhaps outcomes from a larger population would make it possible
to obtain a result that justifies the inclusion of this element in the
treatment of NEC. In cases of NEC, applications of microbiolog-
ical diagnostics are very limited and there is a lack of studies on the
effectiveness of the diagnostic tests on antibiotic usage. In the
tested NECs, reliable microbiological tests were performed in a
little over half of the cases.
In most of the NICUs, a shorter duration of antibiotic treatment
was accompanied by lower antibiotic usage as expressed by the
DDD rate, both when analyses were conducted for all cases of
infection and in the case of dividing NEC patients into two groups,
those with and without microbiological tests. The results of this
data analysis of antibiotic consumption allow us to draw two
conclusions: one regarding the choice of the method for
benchmarking data between different hospitals, and the effective-
ness of antibiotic treatment based on the results of microbiological
tests in NEC cases.
Despite the limitation of DDD in regard to child populations,
this kind of measure may be used for benchmarking purposes as
well as the days of treatment (DOTs) rate; the level of antibiotic
consumption and its differentiation in the two analysed groups in
this study were similarly reflected by both indicators.
The shorter duration of antibiotic treatments and lower values
of DDDs in each analysed ward in groups of NEC cases as
compared to the group without microbiological examination
confirmed the necessity and reasonability of routine microbiolog-
Table 4. Antibiotic usage in NEC cases with and without microbiology tests.
DOTs [days] DOTs per number of NEC DDDs [no] DDDs per number of NEC
Ward with* without** with* without** with* without** with* without**
A 32 66 10.7 13.2 0.4 2.3 0.1 0.4
B 102 0 9.3 ns 0.2 0 0.2 ns
C 154 168 51.3 42.0 2.9 3.4 0.7 0.8
D 23 195 11.5 32.5 0.5 3.9 0.2 0.7
E 61 315 15.3 39.4 0.2 8.1 0.4 1.0
F 0 321 ns 20.1 0 4.3 ns 0.3
TOTAL 372 1 065 18.6 28.0 7.5 21.9 0.4 0.6
*cases of NEC with isolated microbiological agent; **cases of NEC without isolated microbiological agent;
DOTs – days of treatment; DDD – defined daily dose; NEC – necrotizing enterocolitis.
doi:10.1371/journal.pone.0092865.t004
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ical testing to detect infections. Microbiological diagnostics in
Polish hospitals are still regarded as expensive procedures and,
consequently, are often performed only in cases of empiric
treatment failure. However, a shorter treatment results in lower
expenditures on antimicrobials, which should be taken into
account during an analysis of the cost-effectiveness of microbio-
logical testing for hospitalised patients.
However, irrespective of the test method, the antibiotic
associated with NEC employed in the studied NICUs differs from
the schemes suggested in literature [22].
The presented observation has also some limitations. The group
studied, although diverse in terms of prevalence of risk factors for
infection, includes only VLBW infants. The results would probably
be more telling if the survey covered the entire population of
NICU newborns. But the main limitation of our study is very low
number of NEC cases, but this is due to the specific nature of the
disease and the specific population, i.e., VLBW infants. Confir-
mation of significant methodological limitations is that the
mortality associated with NEC in this study was not significantly
lower than the mortality in the control group, mainly due to the
high overall perinatal mortality of VLBW infants.
On the other hand, is NEC truly an infection? A clear
interpretation is lacking.
Conclusions
A high risk of developing NEC is closely associated with VLBW
and with inflammation of the amnion during labour. We observed
no relationship between the consumption of antibiotics in neonates
with NEC and positive results of microbiological testing indicating
sepsis accompanying NEC or gut colonization with pathogens.
Whilst it is important to raise awareness of use of antibiotics
without clear microbiological reason, for NEC this is common
practice and it is difficult to imagine how this could be changed.
Unfortunately, in this case there is no simple solution. Thus,
further detailed studies on the purpose, and usefulness, of the
microbiological diagnosis of sepsis and gut colonization by
pathogens in order to rationalize the use of antibiotics in NEC
seem to be desirable.
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